Q2 EPS Estimates for Owens & Minor Increased by Analyst

Owens & Minor, Inc. (NYSE:OMI) – Research analysts at Leerink Partnrs increased their Q2 2025 EPS estimates for Owens & Minor in a note issued to investors on Thursday, May 8th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $0.30 per share for the quarter, up from their prior forecast of $0.29. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s Q3 2025 earnings at $0.53 EPS, FY2025 earnings at $1.63 EPS and FY2028 earnings at $2.76 EPS.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Saturday, May 10th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.03. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. During the same period in the prior year, the company earned $0.19 earnings per share. The company’s revenue was up .7% compared to the same quarter last year.

OMI has been the subject of a number of other research reports. UBS Group decreased their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Robert W. Baird raised their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. JPMorgan Chase & Co. decreased their target price on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating for the company in a research note on Monday, March 10th. Finally, Citigroup decreased their target price on shares of Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, April 17th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Owens & Minor currently has an average rating of “Hold” and a consensus price target of $12.50.

Owens & Minor Price Performance

OMI stock opened at $7.16 on Monday. Owens & Minor has a 1 year low of $6.07 and a 1 year high of $21.02. The firm has a 50-day moving average of $8.08 and a 200 day moving average of $10.73. The company has a market cap of $552.76 million, a P/E ratio of -11.01, a PEG ratio of 0.20 and a beta of 1.38. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45.

Institutional Investors Weigh In On Owens & Minor

A number of institutional investors have recently made changes to their positions in OMI. Coliseum Capital Management LLC grew its holdings in shares of Owens & Minor by 31.3% during the fourth quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company’s stock valued at $62,553,000 after buying an additional 1,141,483 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Owens & Minor by 19.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,752,960 shares of the company’s stock worth $24,859,000 after purchasing an additional 447,917 shares during the last quarter. Federated Hermes Inc. purchased a new stake in Owens & Minor in the first quarter worth approximately $3,870,000. Nuveen LLC purchased a new stake in Owens & Minor in the first quarter worth approximately $3,729,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Owens & Minor by 133.1% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 703,050 shares of the company’s stock worth $6,349,000 after purchasing an additional 401,472 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Insider Activity

In other news, major shareholder Coliseum Capital Management, L purchased 354,901 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were purchased at an average price of $9.19 per share, for a total transaction of $3,261,540.19. Following the completion of the acquisition, the insider now directly owns 9,824,599 shares in the company, valued at $90,288,064.81. This represents a 3.75% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have bought a total of 2,718,412 shares of company stock worth $24,495,308 over the last 90 days. 3.69% of the stock is currently owned by insiders.

Owens & Minor announced that its Board of Directors has initiated a stock buyback program on Friday, February 28th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 13.6% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.